Product logins

Find logins to all Clarivate products below.


Obesity Interventions – Market Insights – Latin America

The Latin American obesity intervention market will grow through 2026, driven by an increasing obese population and growth of bariatric surgery utilization as a result of positive clinical results and broader acceptance of these procedures in the region. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for obesity intervention in Latin America across a 10-year period.

In several Latin American countries, sales of intragastric balloons will be bolstered by improved physician marketing and awareness.

Which countries will experience the greatest increase in balloon sales?

Which companies successfully market to physicians and what are their market shares?

Insurance coverage varies across the countries and greatly impacts the types of procedures Latin American patients choose to undergo.

How does the availability of insurance differ across the countries?

How does varying insurance coverage impact patients’ choices of treatment?

Several emerging devices are expected to enter the Latin American market within the forecast period.

Which products will enter the Latin American market and when?

How does the approval process in Latin America impact which emerging products will enter the region?

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…